<bill session="117" type="s" number="3700" updated="2022-12-29T21:33:29Z">
  <state datetime="2022-02-17">REFERRED</state>
  <status>
    <introduced datetime="2022-02-17"/>
  </status>
  <introduced datetime="2022-02-17"/>
  <titles>
    <title type="display">Affordable Insulin Now Act</title>
    <title type="short" as="introduced">Affordable Insulin Now Act</title>
    <title type="official" as="introduced">A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans.</title>
  </titles>
  <sponsor bioguide_id="W000790"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2022-02-17"/>
    <cosponsor bioguide_id="B001267" joined="2022-02-17"/>
    <cosponsor bioguide_id="B001277" joined="2022-02-17"/>
    <cosponsor bioguide_id="B001288" joined="2022-02-17"/>
    <cosponsor bioguide_id="B000944" joined="2022-03-02"/>
    <cosponsor bioguide_id="C000174" joined="2022-04-26"/>
    <cosponsor bioguide_id="C001070" joined="2022-03-10"/>
    <cosponsor bioguide_id="C001113" joined="2022-03-02"/>
    <cosponsor bioguide_id="D000622" joined="2022-03-22"/>
    <cosponsor bioguide_id="D000563" joined="2022-02-17"/>
    <cosponsor bioguide_id="F000062" joined="2022-03-29"/>
    <cosponsor bioguide_id="H001076" joined="2022-02-17"/>
    <cosponsor bioguide_id="H001046" joined="2022-03-23"/>
    <cosponsor bioguide_id="H000273" joined="2022-03-10"/>
    <cosponsor bioguide_id="H001042" joined="2022-02-17"/>
    <cosponsor bioguide_id="K000384" joined="2022-03-29"/>
    <cosponsor bioguide_id="K000377" joined="2022-02-17"/>
    <cosponsor bioguide_id="K000383" joined="2022-02-17"/>
    <cosponsor bioguide_id="K000367" joined="2022-02-17"/>
    <cosponsor bioguide_id="L000570" joined="2022-04-26"/>
    <cosponsor bioguide_id="M001183" joined="2022-03-02"/>
    <cosponsor bioguide_id="M000639" joined="2022-03-10"/>
    <cosponsor bioguide_id="M001176" joined="2022-03-08"/>
    <cosponsor bioguide_id="M001169" joined="2022-02-17"/>
    <cosponsor bioguide_id="P000145" joined="2022-02-17"/>
    <cosponsor bioguide_id="P000595" joined="2022-03-02"/>
    <cosponsor bioguide_id="R000122" joined="2022-02-17"/>
    <cosponsor bioguide_id="R000608" joined="2022-03-02"/>
    <cosponsor bioguide_id="S000148" joined="2022-02-17"/>
    <cosponsor bioguide_id="S001181" joined="2022-02-17"/>
    <cosponsor bioguide_id="S001191" joined="2022-03-17"/>
    <cosponsor bioguide_id="S001203" joined="2022-02-17"/>
    <cosponsor bioguide_id="S000770" joined="2022-02-17"/>
    <cosponsor bioguide_id="V000128" joined="2022-02-17"/>
    <cosponsor bioguide_id="W000802" joined="2022-03-02"/>
    <cosponsor bioguide_id="W000779" joined="2022-02-17"/>
  </cosponsors>
  <actions>
    <action datetime="2022-02-17">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-02-17" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="6833" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Appropriations"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug therapy"/>
    <term name="Employee benefits and pensions"/>
    <term name="Executive agency funding and structure"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2022-03-25T16:03:42Z" status="Introduced in Senate">Affordable Insulin Now Act

This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023.

The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare &amp; Medicaid Services (CMS) to implement the bill.

Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.</summary>
</bill>
